was shown that single neurons tend to express specific cadherin subtypes. CDH7 is expressed in the developing eye and in the retina of mice.
In the United States, over 700 000 newborns are exposed in utero to maternal cigarette smoking each year. Prenatal exposure to maternal cigarette smoking (PEMCS) has been associated with a number of molecular, neuroanatomical and behavioral modifications in the humans and experimental animals. 1 This paper describes an interaction between this in utero environment and genetic background vis-à-vis drug use during adolescence. We present behavioral and structural imaging data collected in 423 adolescents (12-18 years of age), half of whom were exposed in utero to maternal cigarette smoking. We show a significant interaction between the presence of a single nucleotide variant in the gene coding an a6 nicotinic acetylcholine receptor (nAChR) and this adverse environment in influencing substance use and brain structure during adolescence.
We have shown previously that PEMCS increases adolescent substance use in relation to the thinning of the orbitofrontal cortex. 2 Nicotine, the main psychoactive component in cigarette smoke, acts on nAChRs to modulate the release of various neurotransmitters, such as dopamine. Studies in experimental animals have provided evidence suggesting that prenatal and adolescent exposure to nicotine alters both the quantity and function of nAChRs located on dopamine neurons in the substantia nigra and ventral tegmental area.
1 Such long-term modifications of nAChRs and, in turn, the dopaminergic system might represent a mechanism involved in a number of psychiatric disorders, including attentiondeficit hyperactivity disorder, schizophrenia and drug abuse. 1 (2-10) and three b subunits (2) (3) (4) . Previous research has focused on the role of the high-affinity a4b2 nicotinic receptor in mediating the rewarding effects of cigarettes. 1 The pharmacology of the nicotinic receptor is, however, remarkably complex. Recent findings have illustrated that the a6 subunit also interacts with the a4b2 subunit to form functional pentameric receptors dominating drug-induced dopamine release in reward-related centers of the brain. 3, 4 In the cell bodies of the substantia nigra and the ventral tegmental area of the rat, the a6 nAChR mRNA is present in utero, its expression increases after birth and peaks during adolescence. 5 The a6 nAChR subunit is also highly expressed in terminal fields of dopaminergic neurons in the dorsal and ventral striatum. 3 This localization of the a6 nAChR suggests that modifications in its quantity and/or function could influence reward-related behavior. It is therefore not surprising that two recent population studies reported an association between a polymorphism in the a6 nAChR gene (rs2304297) and cigarette use. 6, 7 Our current data provide support for this hypothesis but also suggest that PEMCS interacts with this polymorphism (1) to increase the likelihood of adolescent cigarette smoking and substance and (2) to modify the volume of dopamine-rich regions of the striatum ( Figure 1 ).
These findings were obtained in the ongoing Saguenay Youth Study that is aimed at evaluating the effects of PEMCS on brain and behavior, and cardiovascular and metabolic health in adolescent offspring; non-exposed adolescents are matched to exposed ones by maternal education. 8 In a population of 423 adolescents, we have collected information about the life history of smoking ( Figure 1a ) as well as of drug experimentation ( Figure 1b ) using a selfreport questionnaire in which a total of 14 questions are asked about the use of drugs, including alcohol, marijuana and other illicit drugs, namely stimulants, psychedelics, phencyclidine, ecstasy, prescription drugs, inhalers, cocaine, opiates, tranquilizers, heroin, anabolic steroids and other not-listed drugs. Magnetic resonance T1-weighted images (1-mm isotropic) were acquired on a Phillips 1.0-T superconducting magnet (Gyroscan NT, Philips Healthcare, Best, The Netherlands). Using FreeSurfer, 9 we estimated the total volume of the striatum defined as a sum of the caudate nucleus, putamen and nucleus accumbens (Figure 1c) . We genotyped the a6 nAChR SNP (rs2304297, C/G), with the minor C allele, using KASPar (KBioscience, Herts, UK). KASPar is a competitive allele-specific PCR-based SNP fluorescent genotyping system that uses FRET quencher cassette oligos.
We found a significant interaction between PEMCS and the a6 nAChR SNP in predicting adolescent lifetime cigarette smoking ( Figure 1a , w 2 (3, 419) = 3.87, P < 0.05) and substance use (Figure 1b , w 2 (3, 419) = 6.16, P < 0.02; Poisson distributed). Post-hoc analysis revealed that 'exposed' GG adolescents with the GG genotype have tried more cigarettes/drugs in their lifetime than all other groups by nearly 50% (P < 0.05), suggesting that the presence of this genotype moderates the effect of PEMCS on cigarette/drug use. As the a6 subunit is highly expressed in the striatum, we then evaluated differences in the volume of this brain structure, corrected for age, sex and brain size, vis-à-vis the interaction between the a6 variant and PEMCS; the interaction was significant (Figure 1c , F (6, 422) = 2.32 P = 0.02). Subsequent post-hoc analysis revealed significant differences between individuals with GG and C-carriers in the exposed group (P < 0.02).
Although the functional consequences of the a6 nAChR SNP at the receptor level are unknown, the polymorphism is found in the 3 0 -untranslated region (UTR). As others have reported, 7 the 3 0 -untranslated region has a number of regulatory regions known to influence the expression of the subunit through trafficking of mRNA, miRNA binding and/or rate of mRNA degradation. Therefore, a polymorphism in the 3 0 -untranslated region could alter the overall quantity of this subunit in the brain. Alterations in the quantity of these receptors may lower dopamine content in the brain and increase the size of the striatum as seen in experimental animals and humans treated chronically with neuroleptics. 10 As previously proposed, 11 a hypodopaminergic state may also mediate the increase in the size of the striatum seen in chronic drug users. In conclusion, our findings highlight the negative consequences of PEMCS on the brain and behavior of adolescence and suggest that the a6 nAChR subunit may modify, at least in part, these effects. Human and canine compulsive disorders (CCDs) manifest as time-consuming, repetitive behaviors causing distress and functional impairment. CCDs derive from normal behaviors such as grooming (acral lick dermatitis), predatory behavior (tail chasing, fly snapping), eating/suckling (pica and flank sucking (FS)/blanket sucking (BS)) or locomotion (pacing/ circling). They commonly appear between pre-pubescence and early social maturity 1 and may be precipitated by anxiety or stress. However, the behavior soon becomes 'fixed' and is shown even in the absence of obvious stressors. CCD has compelling parallels with human obsessive-compulsive disorder (OCD).
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2,3 OCD, characterized by recurring obsessions and/or compulsions, affects millions of individuals. 4 Here, we describe the novel association of Doberman pincher CCD with a chromosome 7 locus containing CDH2, an attractive candidate.
Genome-wide association analyses were performed using DNA from 92 rigorously phenotyped Doberman pinscher FS/BS cases and 68 controls 5 obtained under the Institute of Animal Care Use Committee protocol consent. The median onset age was 4.8 months for BS and 8.5 months for FS. 6 DNA was genotyped on the Affymetrix v2 canine single-nucleotide polymorphism (SNP) array. 5 After quality filtering, genomewide association of the resulting 14 700 SNPs to CCD was performed using PLINK. Only three chromosome 7 SNPs (between 61.83 to 63.87 Mb) had P < 0.1 after permutation testing; the most significant SNP was at 63.867472 Mb (P raw = 7.6 Â 10 À7 and P genome = 0.013, Figure 1a ,b). Weaker associations on chromosomes 18, 33, 34 and 38 failed to reach genome-wide significance.
Fine-mapping using 84 SNPs across 1.7 Mb surrounding the chromosome 7 peak, including nine SNPs from the genome-wide analysis, was performed on an increased sample number (94 affected; 73 controls). After analyzing 63 SNPs passing quality filters, the association peak remained at 63.867472 Mb (P raw = 5.5 Â 10 À6 ). Multi-SNP haplotype testing revealed an extended region of moderate association spanning roughly 400 kb (63.8-64.2 Mb), likely reflecting the long haplotypes found within dog breeds. The most significantly associated SNP is located within CDH2 (Figure 1c) . CDH2 is widely expressed, mediating synaptic activity-regulated neuronal adhesion. 7 Dogs showing multiple compulsive behaviors have a higher frequency of the risk allele than dogs with a less severe phenotype (60 and 43%, respectively, compared with 22% in unaffected dogs; Figure 1d ).
The highly significant association of CCD with the CDH2 region on chromosome 7 is the first genetic locus identified for any animal compulsive disorder, and raises the intriguing possibility that CDH2 and other neuronal adhesion proteins are involved in human compulsive behaviors. A genetic association of cadherins with autism spectrum disorder, which often includes repetitive and compulsive behaviors, has also recently been reported. 8 As little is known about the underlying molecular mechanisms for compulsive behaviors, this discovery could provide
